XML 35 R28.htm IDEA: XBRL DOCUMENT v3.25.3
Basis of Presentation and Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Fair Value Measurement Specific to Assets or Liability

 

Fair Value Measurements at Reporting Date Using (in thousands)

 

 

Balances as of
September 30, 2025

 

 

Quoted Prices in
Active Markets for
Identical
Assets/Liabilities
(Level 1)

 

 

Significant Other
Observable Inputs
(Level 2)

 

 

Significant
Unobservable Inputs
(Level 3)

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

91,481

 

 

$

91,481

 

 

$

 

 

$

 

U.S. Treasuries

 

$

473,831

 

 

$

473,831

 

 

$

 

 

$

 

Investment in equity securities:

 

 

 

 

 

 

 

 

 

 

 

 

Equity securities

 

$

19,167

 

 

$

19,167

 

 

$

 

 

$

 

 

 

Fair Value Measurements at Reporting Date Using (in thousands)

 

 

Balances as of
December 31,
2024

 

 

Quoted Prices in
Active Markets for
Identical
Assets/Liabilities
(Level 1)

 

 

Significant Other
Observable Inputs
(Level 2)

 

 

Significant
Unobservable Inputs
(Level 3)

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

109,947

 

 

$

109,947

 

 

$

 

 

$

 

U.S. Treasuries

 

$

329,457

 

 

$

329,457

 

 

$

 

 

$

 

Investment in equity securities:

 

 

 

 

 

 

 

 

 

 

 

 

Equity securities

 

$

21,564

 

 

$

21,564

 

 

$

 

 

$

 

Summary of Disaggregated Product Revenue

The following table summarizes the Company’s net product revenue disaggregated by product (in thousands):

 

 

For the Three Months Ended September 30,

 

 

For the Nine Months Ended September 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

FIRDAPSE®

 

$

92,181

 

 

$

79,303

 

 

$

260,757

 

 

$

223,517

 

FYCOMPA®

 

 

23,804

 

 

 

32,075

 

 

 

93,763

 

 

 

99,035

 

AGAMREE®*

 

 

32,380

 

 

 

15,046

 

 

 

81,785

 

 

 

24,966

 

Total product revenue, net

 

$

148,365

 

 

$

126,424

 

 

$

436,305

 

 

$

347,518

 

_________________

*AGAMREE® net product revenue for the nine months ended September 30, 2024 is for the period between March 13, 2024 (date of commercial launch) and September 30, 2024.

Summary of Percentage of the Company's Total Net Product Revenue

The following table illustrates the approximate percentage of the Company’s total net product revenue attributed to the Company’s largest customers for the periods presented:

 

 

For the Three Months Ended September 30,

 

 

For the Nine Months Ended September 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Customer A

 

 

84.0

%

 

 

74.6

%

 

 

78.2

%

 

 

71.5

%

Customer B

 

 

5.7

%

 

 

9.4

%

 

 

7.9

%

 

 

10.0

%

Total

 

 

89.7

%

 

 

84.0

%

 

 

86.1

%

 

 

81.5

%

Basic and Dilutive Weighted Average Common Shares

The following table reconciles basic and diluted weighted average common shares:

 

For the Three Months Ended September 30,

 

 

For the Nine Months Ended September 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Basic weighted average common shares
   outstanding

 

 

122,600,730

 

 

 

118,931,153

 

 

 

122,082,914

 

 

 

117,976,056

 

Effect of dilutive securities

 

 

4,489,464

 

 

 

6,476,126

 

 

 

5,119,040

 

 

 

6,543,782

 

Diluted weighted average common shares
   outstanding

 

 

127,090,194

 

 

 

125,407,279

 

 

 

127,201,954

 

 

 

124,519,838

 

Schedule of Significant Segment Expenses of Stock-based Compensation

The following table illustrates information about significant segment expenses, inclusive of stock-based compensation:

 

 

For the Three Months Ended September 30,

 

 

For the Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Research and development

 

$

2,657

 

 

$

3,284

 

 

$

10,902

 

 

$

8,850

 

Selling

 

 

32,512

 

 

 

30,966

 

 

 

95,745

 

 

 

86,064

 

General and administrative (a)

 

 

14,958

 

 

 

14,914

 

 

 

44,585

 

 

 

47,484

 

Total

 

$

50,127

 

 

$

49,164

 

 

$

151,232

 

 

$

142,398

 

__________________________________________

(a) exclusive of amortization of intangible assets